Latest filing published 23 Jun 2021 for ExpreS2ion Biotech Holding AB (EXPRS2), €6,838.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -68.7%Entry 547.50 · Close at T+365 171.31
- -69.2%Entry 556.93 · Close at T+365 171.31
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Eske RygaardHjalsted: trading record in brief
This profile gathers the share dealings of Eske RygaardHjalsted in ExpreS2ion Biotech Holding AB (EXPRS2). We count 2 filings; the first trade dates from 17 June 2021 and the latest from 23 June 2021.
Every open-market trade on record is a purchase: 2 purchases worth €18k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 23 June 2021: an open-market purchase of €6,838, in ExpreS2ion Biotech Holding AB (EXPRS2). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Eske RygaardHjalsted
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ SEK 34.6037.8% of flowAktieISIN SE0008348262FI:csv-5a09bf237610396f87ebCanonical exit: 21 Sept 2021 (T+90)
- 3,125 shares@ SEK 36.7562.2% of flowAktieISIN SE0008348262FI:csv-702653a7be05f004b43aCanonical exit: 15 Sept 2021 (T+90)
2 of 2 declarations